Tuesday, June 3, 2014

Announcing the Tarceva® Forecast Model

We at BCC Research are excited to announce the launch of the long term forecasting model for lung cancer drug Tarceva®, and we are offering you a complimentary introductory sample of the product.

The BCC Research Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters.

Click here to download an introductory sample of the Tarceva® Forecast Model.

The model features:

  • Market demand forecasts for Tarceva® annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
  • Segmentation of volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, Middle East
  • Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence
Click here to view a data sheet of the Tarceva® Forecast Model.

Use the BCC Research Tarceva® Forecast to:
  • Examine forecasted market demand for Tarceva®: competitor assessment; market opportunity assessment
  • Identify new business and investment opportunities for products in the lung cancer segment
  • Validate other Tarceva® market-demand data to which you have access

Questions? How can we help you?  Contact us:
(+1) 781-489-7301, ext. 1

No comments:

Post a Comment

Bookmark and Share